Know Cancer

or
forgot password

Integrated Whole-Genome Analysis of Hematologic Disorders Using High-Throughput Sequencing and Array Technologies


N/A
18 Years
N/A
Open (Enrolling)
Both
Hematologic Diseases

Thank you

Trial Information

Integrated Whole-Genome Analysis of Hematologic Disorders Using High-Throughput Sequencing and Array Technologies


Inclusion Criteria:



1. 18 years of age or older

2. Patient meets the clinical and/or pathologic criteria for the hematologic disorder
being examined.

3. Patient is willing to provide a skin biopsy and five 10 mL tubes of peripheral blood.

Exclusion Criteria:

1. Less than 18 years of age

2. Patient is not willing to provide a skin biopsy and five 10 mL tubes of peripheral
blood.

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Principal Investigator

James L Zehnder

Investigator Role:

Principal Investigator

Investigator Affiliation:

Stanford University

Authority:

United States: Institutional Review Board

Study ID:

HEM0013

NCT ID:

NCT01108159

Start Date:

September 2009

Completion Date:

Related Keywords:

  • Hematologic Diseases
  • Hematologic Diseases

Name

Location

Stanford University School of MedicineStanford, California  94305-5317